Newsletter Signup | Join Community
Stay Current With Ovarian Cancer Treatment Advances & Connect with Others
Zejula in Combination With Keytruda Appears Promising in Patients With Platinum Resistant/Refractory Ovarian Cancer.
Combination of novel precision cancer medicines represents future direction of ovarian cancer treatment.
Answers to frequently asked questions about CA 125.
NEJM publication - the precision cancer medicine Lynparza will change the way ovarian cancer is treated.
Research suggests new immunotherapy combination treatment is promising for ovarian cancer.
Looking for Long Term Survivors:
Great NOCC overview on maintenance therapy for ovarian cancer.
Speak up and share your story of hope!